Summary of GLORIA-AF Final Phase II: Two-year safety and effectiveness of dabigatran in patients with atrial fibrillation (summarized by Prof Gregory Lip). An educational video summarizing data presented at EHRA, Barcelona 2018.
GLORIA-AF Final Phase II Two-year safety and effectiveness of dabigatran in AF patients (GYH Lip)
May 8, 2019
Keep up to date with our latest
articles and journals